Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 2, 2018
The extracellular domain of Her2 in serum as a biomarker of breast cancer
Alexandre Perrier, Joseph Gligorov, Guillaume Lefèvre, et al.
Bulletin Du Cancer
|
December 19, 2022
Léo Mas, Alexandre Perrier, Florence Coulet, et al.
Biomolecules
|
July 26, 2020
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Alexandre Perrier, Audrey Didelot, Pierre Laurent-Puig, et al.
Frontiers in Oncology
|
July 14, 2023
Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports
Lionel Michaux, Alexandre Perrier, Camille Mehlman, et al.
Molecular Diagnosis & Therapy
|
February 3, 2025
Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital
Franck Neil El Sissy, Annouk Bisdorff, Alexandre Perrier, et al.
Plos One
|
January 8, 2020
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies
Alexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, et al.
Therapeutic Advances in Medical Oncology
|
March 31, 2025
Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with <i>EGFR</i> exon 19 deletion: a case report and literature review
Timothée Vigié, Alexandre Perrier, Brice Chanez, et al.
Bulletin Du Cancer
|
January 11, 2022
[Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]
Alexandre Perrier, Pierre Hainaut, Pierre-Jean Lamy, et al.
Bulletin Du Cancer
|
January 17, 2022
[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers]
Alexandre Perrier, Pierre Hainaut, Alexandre Guenoun, et al.
European Journal of Human Genetics : EJHG
|
March 12, 2022
Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data
Mélanie Eyries, Olivier Ariste, Gaelle Legrand, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 2, 2018
The extracellular domain of Her2 in serum as a biomarker of breast cancer
Alexandre Perrier, Joseph Gligorov, Guillaume Lefèvre, et al.
Bulletin Du Cancer
|
December 19, 2022
Léo Mas, Alexandre Perrier, Florence Coulet, et al.
Biomolecules
|
July 26, 2020
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Alexandre Perrier, Audrey Didelot, Pierre Laurent-Puig, et al.
Frontiers in Oncology
|
July 14, 2023
Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports
Lionel Michaux, Alexandre Perrier, Camille Mehlman, et al.
Molecular Diagnosis & Therapy
|
February 3, 2025
Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital
Franck Neil El Sissy, Annouk Bisdorff, Alexandre Perrier, et al.
Plos One
|
January 8, 2020
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies
Alexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, et al.
Therapeutic Advances in Medical Oncology
|
March 31, 2025
Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with <i>EGFR</i> exon 19 deletion: a case report and literature review
Timothée Vigié, Alexandre Perrier, Brice Chanez, et al.
Bulletin Du Cancer
|
January 11, 2022
[Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]
Alexandre Perrier, Pierre Hainaut, Pierre-Jean Lamy, et al.
Bulletin Du Cancer
|
January 17, 2022
[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers]
Alexandre Perrier, Pierre Hainaut, Alexandre Guenoun, et al.
European Journal of Human Genetics : EJHG
|
March 12, 2022
Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data
Mélanie Eyries, Olivier Ariste, Gaelle Legrand, et al.
Page
of 3